ID
34157
Description
A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01363986
Link
https://clinicaltrials.gov/show/NCT01363986
Keywords
Versions (1)
- 1/14/19 1/14/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 14, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT01363986
Eligibility Breast Cancer NCT01363986
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Breast Cancer NCT01363986
- StudyEvent: Eligibility